Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2020 17:00 ET | Source: Acasti Pharma, Inc.

Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements

LAVAL, Québec, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development...
February 28, 2020 08:59 ET | Source: Medexus Pharmaceuticals Inc

Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®

Acquisition Expected to be Immediately Accretive to Adjusted EBITDA1 Announces US$20 Million Credit Facility with MidCap Financial TORONTO and CHICAGO and MONTREAL, Feb. 28, 2020 (GLOBE NEWSWIRE)...
February 26, 2020 11:27 ET | Source: Reliance Global Group, Inc.

Reliance Global Group CEO Interviewed on Proactiveinvestors.com; Lays Out Vision for Investment and Strategic Partnership With Nsure.com

LAKEWOOD, NJ, Feb. 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reliance Global Group, Inc. (OTCQB: RELI) ("RELI" or the "Company"), today announced that Ezra Beyman, Chief Executive Officer of...
February 25, 2020 08:30 ET | Source: Touchpoint Group Holdings Inc.

Touchpoint Group Holdings Announces Sale of Browning Productions & Entertainment, Inc.

MIAMI, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Touchpoint Group Holdings, Inc. (OTCQB: TGHI) (Company or Touchpoint) a media and digital technology holding company, today announced the sale of Browning...
February 24, 2020 09:00 ET | Source: Artelo Biosciences

Artelo Biosciences to Present at Biocom’s 10th Annual Global Life Sciences Partnering Conference

LA JOLLA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid...
February 24, 2020 08:30 ET | Source: Avalon GloboCare Corp.

Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020

FREEHOLD, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it will...
February 20, 2020 10:00 ET | Source: Reliance Global Group, Inc.

Reliance Global Group Inc. Announces Strategic Partnership and Investment Into NSURE, Inc., America’s First Licensed Digital Insurance Agency®

Nsure.com poised to disrupt $340 billion home and auto insurance market LAKEWOOD, NJ, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reliance Global Group, Inc. (OTCQB: RELI)...
February 19, 2020 08:30 ET | Source: Surge Holdings, Inc.

Surge Holdings Reports Rapid Growth in Surge Logics; Surge Logics Sales Increase Nearly 10-Fold in January 2020 Versus Same Period Last Year

Memphis, TN, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Surge Holdings, Inc. (“Surge”) (OTCQB: SURG), developer of the SurgePays™ Marketplace Network for convenience stores, bodegas and community markets...
February 19, 2020 06:00 ET | Source: Orgenesis Inc.

Orgenesis Announces Collaboration with The John Hopkins University for the Development and Processing of Cell and Gene Based Clinical Therapeutics

GERMANTOWN, Md., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a provider of point-of-care cell and gene therapy development, processing and treatment solutions (“POCare”), today...
February 18, 2020 18:52 ET | Source: Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Reports Revenue of $16.2 Million for the Third Quarter of Fiscal 2020

Q3 2020 Metoject® unit market demand increased 88%1; Rupall™ unit market demand increased 62%2; and Rasuvo® unit market demand increased 8%3 Management to host conference call at 8:00 AM ET on...